Loading...
0
New

Sexually Transmitted Diseases (STD) Testing Market by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, and Others), and Location of Testing (Laboratory Testing and POC Testing): Global Opportunity Analysis and Industry Forecast, 2018–2025

LI_14385
Pages: 110
May 2019 | 10558 Views
 
Author(s) : Sagar Mukhekar & Onkar Sumant , Onkar Sumant
Tables: 40
Charts: NA
 

Std Testing Market Outlook - 2025

The global STD testing market was valued at $ 86,548.0 million in 2017 and is estimated to reach $ 133,935.7 million by 2025, growing at a CAGR of 5.6% from 2018 to 2025.

Sexually transmitted diseases are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases. The STD testing market has witnessed significant growth in the past decade with increasing prevalence of STDs. With high prevalence, coverage of STD diagnosis facilities has also majorly increased in the developed countries. However, in developing regions, STD diagnosis facilities are still inadequate to provide wider coverage to the population with STDs. Inadequate facilities for STD diagnosis are considered to be the major concern in developing regions.

STDs have witnessed substantial growth in their prevalence and incidents in the past decade. With increasing prevalence, respective countries across the world are focusing on implementation of national screening programs to expand the coverage of STD diagnosis. Moreover, reimbursement policies have also been favorable for STD services. These factors are significantly driving the growth of the global STD testing market. On the other hand, limited access to STD diagnosis in developing regions is expected to restrain the market growth.

STD Testing Market

Get more information on this report : Request Sample Pages

GLOBAL STD TESTING MARKET SEGMENTATION

The global STD testing market is segmented based on disease type, location of testing, and region. Based on disease type, it is bifurcated into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus testing, and others. Based on location of testing, the market is categorized into laboratory testing, and point of care (PoC) testing. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

STD Testing Market By Region

Get more information on this report : Request Sample Pages

Segment review

According to disease type, the chlamydia segment is the highest revenue contributor and gonorrhea is expected to exhibit the fastest growth rate of 8.9%. This is attributed to the increased prevalence of gonorrhea in the last decade.

STD Testing Market By Type

Get more information on this report : Request Sample Pages

By location of testing, the laboratory testing segment occupied the largest share of STD testing market in 2017. POC testing segment is expected to grow at the highest rate during the forecast period. Factors such as faster diagnosis with POC tests and expected rise in adoption of POCs in future significantly contribute toward the growth of this segment.

STD Testing Market By Testing

Get more information on this report : Request Sample Pages

Key Benefits for Std Testing Market:

  • This report entails a detailed quantitative analysis along with the current global STD testing market trends from 2017 to 2025 to identify the prevailing opportunities along with the strategic assessment. 
  • The global STD testing market forecast is studied from 2018 to 2025. 
  • The global STD testing market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Std Testing Market Segmentation:

By Disease Type

  • Chlamydia
  • Syphilis
  • Gonorrhea
  • Herpes Simplex Virus
  • Human Papilloma Virus
  • Human Immunodeficiency Virus 
  • Others

By Location of Testing

  • Laboratory Testing
  • Point of Care (POC) Testing

By Region

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • South Africa
    • Other African Countries
 

CHAPTER 1:INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY MARKET SEGMENTS
1.3.KEY BENEFITS
1.4.RESEARCH METHODOLOGY

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO PERSPECTIVE

CHAPTER 3:MARKET OVERVIEW


3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.MARKET DYNAMICS

3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities

CHAPTER 4:STD TESTING MARKET BY DISEASE TYPE

4.1.OVERVIEW
4.2. CHLAMYDIA

4.2.1.Key market trends, Growth factors and opportunities
4.2.2.Market size and forecast by region
4.2.3.Market volume and forecast by region

4.3. GONORRHEA

4.3.1.Key market trends, Growth factors and opportunities
4.3.2.Market size and forecast by region
4.3.3.Market volume and forecast by region

4.4. HERPES SIMPLEX VIRUS

4.4.1.Key market trends, Growth factors and opportunities
4.4.2.Market size and forecast by region
4.4.3.Market volume and forecast by region

4.5. SYPHILIS

4.5.1.Key market trends, Growth factors and opportunities
4.5.2.Market size and forecast by region
4.5.3.Market volume and forecast by region

4.6. HUMAN PAPILLOMA VIRUS

4.6.1.Key market trends, Growth factors and opportunities
4.6.2.Market size and forecast by region
4.6.3.Market volume and forecast by region

4.7. HUMAN IMMUNODEFICIENCY VIRUS

4.7.1.Key market trends, Growth factors and opportunities
4.7.2.Market size and forecast by region
4.7.3.Market volume and forecast by region

4.8. OTHERS

4.8.1.Key market trends, Growth factors and opportunities
4.8.2.Market size and forecast by region
4.8.3.Market volume and forecast by region

CHAPTER 5:STD TESTING MARKET BY LOCATION OF TESTING

5.1.OVERVIEW
5.2. LABORATORY TESTING

5.2.1.Key market trends, Growth factors and opportunities
5.2.2.Market size and forecast by region
5.2.3.Market volume and forecast by region

5.3. POINT OF CARE TESTING

5.3.1.Key market trends, Growth factors and opportunities
5.3.2.Market size and forecast by region
5.3.3.Market volume and forecast by region

CHAPTER 6:STD TESTING MARKET BY REGION

6.1.OVERVIEW
6.2.NORTH AMERICA

6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast by Disease Type
6.2.3.Market size and forecast by Location of Testing

6.3.EUROPE

6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast by Disease Type
6.3.3.Market size and forecast by Location of Testing

6.4.ASIA PACIFIC

6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast by Disease Type
6.4.3.Market size and forecast by Location of Testing

6.5.LAMEA

6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast by Disease Type
6.5.3.Market size and forecast by Location of Testing

CHAPTER 7:COMPANY PROFILES

7.1. ROCHE HOLDINGS AG

7.1.1.Company overview
7.1.2.Business performance
7.1.3.Key strategic moves and developments

7.2. BIOMERIEUX

7.2.1.Company overview
7.2.2.Business performance
7.2.3.Key strategic moves and developments

7.3. HOLOGIC INC

7.3.1.Company overview
7.3.2.Business performance
7.3.3.Key strategic moves and developments

7.4. BECTON DICKINSON COMPANY

7.4.1.Company overview
7.4.2.Business performance
7.4.3.Key strategic moves and developments

7.5. ORASURE

7.5.1.Company overview
7.5.2.Business performance
7.5.3.Key strategic moves and developments

7.6. DANAHER CORPORATION

7.6.1.Company overview
7.6.2.Business performance
7.6.3.Key strategic moves and developments

7.7. AFFYMETRIX

7.7.1.Company overview
7.7.2.Business performance
7.7.3.Key strategic moves and developments

7.8. ABBOTT LABORATORIES

7.8.1.Company overview
7.8.2.Business performance
7.8.3.Key strategic moves and developments

7.9. BIO-RAD LABORATORIES INC

7.9.1.Company overview
7.9.2.Business performance
7.9.3.Key strategic moves and developments

7.10. DIASORIN

7.10.1.Company overview
7.10.2.Business performance
7.10.3.Key strategic moves and developments

*Details on financial performance and strategic moves and developments may not be captured for unlisted companies.
*Market size and forecast will be provided from 2017 - 2025 and forecast period would be 2018 - 2025.

LIST OF TABLES

TABLE 1.GLOBAL STD TESTING MARKET, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 2.STD TESTING MARKET FOR CHLAMYDIA, BY REGION, 2017-2025 ($MILLION)
TABLE 3.STD TESTING MARKET FOR GONORRHEA, BY REGION, 2017-2025 ($MILLION)
TABLE 4.STD TESTING MARKET FOR HERPES SIMPLEX VIRUS, BY REGION, 2017-2025 ($MILLION)
TABLE 5.STD TESTING MARKET FOR SYPHILIS, BY REGION, 2017-2025 ($MILLION)
TABLE 6.STD TESTING MARKET FOR HUMAN PAPILLOMA VIRUS, BY REGION, 2017-2025 ($MILLION)
TABLE 7.STD TESTING MARKET FOR HUMAN IMMUNODEFICIENCY VIRUS, BY REGION, 2017-2025 ($MILLION)
TABLE 8.STD TESTING MARKET FOR OTHERS, BY REGION, 2017-2025 ($MILLION)
TABLE 9.GLOBAL STD TESTING MARKET, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 10.STD TESTING MARKET FOR LABORATORY TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 11.STD TESTING MARKET FOR POINT OF CARE TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 12.STD TESTING MARKET FOR, BY REGION, 2017-2025 ($MILLION)
TABLE 13.NORTH AMERICA STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 14.NORTH AMERICA STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 15.NORTH AMERICA STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 16.EUROPE STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 17.EUROPE STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 18.EUROPE STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 19.ASIA PACIFIC STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 20.ASIA PACIFIC STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 21.ASIA PACIFIC STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 22.LAMEA STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 23.LAMEA STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 24.LAMEA STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 25.ROCHE HOLDINGS AG: COMPANY SNAPSHOT
TABLE 26.ROCHE HOLDINGS AG: OPERATING SEGMENTS
TABLE 27.BIOMERIEUX: COMPANY SNAPSHOT
TABLE 28.BIOMERIEUX: OPERATING SEGMENTS
TABLE 29.HOLOGIC INC: COMPANY SNAPSHOT
TABLE 30.HOLOGIC INC: OPERATING SEGMENTS
TABLE 31.BECTON DICKINSON COMPANY: COMPANY SNAPSHOT
TABLE 32.BECTON DICKINSON COMPANY: OPERATING SEGMENTS
TABLE 33.ORASURE: COMPANY SNAPSHOT
TABLE 34.ORASURE: OPERATING SEGMENTS
TABLE 35.DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 36.DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 37.AFFYMETRIX: COMPANY SNAPSHOT
TABLE 38.AFFYMETRIX: OPERATING SEGMENTS
TABLE 39.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 40.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 41.BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
TABLE 42.BIO-RAD LABORATORIES INC: OPERATING SEGMENTS
TABLE 43.DIASORIN: COMPANY SNAPSHOT
TABLE 44.DIASORIN: OPERATING SEGMENTS

 
 

The adoption of STD is anticipated to witness significant growth due to high prevalence of sexually transmitted diseases in the developing nations. Moreover, the STD testing market has gained immense interest of the healthcare industry due to its major role in diagnosis and treatment of highly prevalent sexually transmitted diseases. Asia-Pacific is projected to register highest growth rate in the global STD testing market due to massive increase in population, high prevalence of sexually transmitted diseases, and rise in the healthcare market.

Rise in incidence rates and increase in prevalence rates of STD, implementation of national screening programs, and support in reimbursement for STD testing are the major factors that drive the market growth. However, there is social stigma associated with patients visiting specialized STD clinics which refrain patients from STD diagnosis. Moreover, huge proportion of patients infected with STDs are based in out-of-reach geographic areas which significantly limits the diagnosis of STDs. Such factors are expected to restrain the market growth.
 

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

Download Sample

OR

Purchase Full Report of
Sexually Transmitted Diseases (STD) Testing Market

  • Online Only
  • $3456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3840
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5370
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample

Buy Full Version
"Sexually Transmitted Diseases (STD) Testing Market"
Purchase Enquiry